Showing 1291-1300 of 3763 results for "".
Antiaging Medicine Meets Aesthetics
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/antiaging-medicine-meets-aesthetics/18883/Antiaging medicine supports overall patient health and can be a complement to aesthetic medicine. Greg Buford, MD talks about anti aging medicine and its role in his practice.Positive Changes in My Practice
https://practicaldermatology.com/topics/practice-management/positive-changes-in-my-practice/19044/Sometimes relatively simple changes can have a big impact on a practice. Steve Yoelin, MD talks about positive changes he has made in his practice.Management of the Periocular Area
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/management-of-the-periocular-area/19210/Richard Anderson, MD reviews his presentation on the proper approach to cosmetic management of the periocular area and mid-face at Vegas Cosmetic Surgery 2013. He discusses blepharoplasty, toxins, fillers, and more. VCS2013Oxidative Stress and Antioxidants in Atopic Dermatitis
https://practicaldermatology.com/programs/practical-dermatology-type-ii-inflammation-journal-club/oxidative-stress-and-antioxidants-in-atopic-dermatitis/50964/Practical Dermatology Associate Medical Editor Elizabeth (Lisa) Swanson, MD, FAAD, and Francisca Kartono, DO, FAAD, discuss the International Journal of Molecular Sciences article “The Role of Oxidative Stress and Antioxidants in the Course of Atopic Dermatitis.”Expanding Access to Care Through a Virtual Platform
https://practicaldermatology.com/videos/c-suite-chats/expanding-access-to-care-through-a-virtual-platform/69071/Patrick Burnett, MD, PhD, FAAD, Chief Medical Officer for Arcutis, discusses a new virtual health platform designed to expand access pathways to roflumilast for chronic inflammatory skin diseases.Zasocitinib Psoriasis Studies Continue to Show Promise
https://practicaldermatology.com/videos/skin-minute/zasocitinib-psoriasis-studies-continue-to-show-promise/67371/Linda Stein Gold, MD, explains the significance of new Phase 3 data on zasocitinib for psoriasis, demonstrating consistent, high rates of skin clearance across the body, including hard-to-treat and high-impact sites.How to Get Young People to Wear Sunscreen
https://practicaldermatology.com/videos/skin-minute/how-to-get-young-people-to-wear-sunscreen/60875/SPOOGE Founder Whitney Hovenic, MD, discusses younger generations' insufficient utilization of sunscreen and the strategies her company has employed in an effort to avoid an increase in melanoma cases in the future.Prurigo Nodularis in Skin of Color: Recognizing Distinct Clinical Presentations
https://practicaldermatology.com/programs/dermatology-hub-neuroimmune-network/prurigo-nodularis-in-skin-of-color-recognizing-distinct-clinical-presentations/57012/Cheri Frey, MD, discusses how prurigo nodularis may present differently in patients with skin of color, highlighting diagnostic challenges, variations in inflammation, and the importance of recognizing disease manifestations across diverse skin tones.TOGETHER-PsO: Dual Therapy for Psoriasis and Obesity
https://practicaldermatology.com/videos/skin-minute/together-pso-dual-therapy-for-psoriasis-and-obesity/57262/Mark G. Lebwohl, MD, provides key takeaways and commentary on the results of the TOGETHER-PsO study, which looked at a combination therapy of ixekizumab (Taltz) and tirzepatide (Zepbound) in patients with both psoriasis and obesity.Chemical Peels for Periocular Lentigines
https://practicaldermatology.com/conferences/noah-worcester/chemical-peels-for-periocular-lentigines/57073/Kachiu Lee, MD, MPH, discusses her presentation, “Treatment of Periocular Lentigines with Chemical Peels: A Clinical Pearl,” from the Noah Worcester Dermatological Society’s 2026 Annual Meeting.